SCHEMBL6015274

SCHEMBL6015274

COc1ccc(Nc2nc(NC(N)=O)c(C(=O)O)s2)cc1.NC(=O)[C@H]1CCCNC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
NPC1 O15118 2/20 0.44
MAPT P10636 2/20 0.42
CDK5 Q00535 2/20 0.42
CDK5R1 Q15078 2/20 0.42
LMNA P02545 1/20 0.42
CHEK1 O14757 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
CYP2D6 P10635 1/20 0.41
SYK P43405 1/20 0.40
TUBB8B A6NNZ2 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40
TUBB2A Q13885 1/20 0.40
TUBB8 Q3ZCM7 1/20 0.40
TUBB6 Q9BUF5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5554766 0.84 MEN1 (0.58) KMT2AMEN1NPC1MAPTCDK5
SCHEMBL1563750 0.83 CHEK1 (0.52) CHEK1SYKPTK2
SCHEMBL6015254 0.78 CHEK1 (0.42) KMT2AMAPTCHEK1KDM4EATM
SCHEMBL6015246 0.77 CHEK1 (0.48) KMT2AMAPTCHEK1KDM4EATM
SCHEMBL6015247 0.76 KDM4E (0.48) KMT2AMAPTLMNACHEK1KDM4E
SCHEMBL6015267 0.75 KMT2A (0.47) KMT2AMAPTLMNACHEK1KDM4E
SCHEMBL6015282 0.75 KDM4E (0.46) KMT2AMAPTLMNACHEK1KDM4E
SCHEMBL13534617 0.74 MEN1 (0.55) KMT2AMEN1NPC1MAPTCDK5
SCHEMBL2446469 0.72 ALOX15 (0.59) NPC1ALOX15
SCHEMBL4476146 0.71 CCNA2 (0.69) KMT2AMEN1NPC1MAPTCDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732920-A2 THIOPHENE DERIVATIVES AS CHK 1 INHIBITORS AstraZeneca AB (SE) 2006-12-20 EP disclosed
WO-2005066163-A2 THIOPHENE DERIVATIVES AS CHK 1 INIHIBITORS ASTRAZENECA AB (SE) 2005-07-21 WO disclosed